Implantable biocompatible immunoisolatory vehicle for delivery of selected therapeutic products
Abstract
[Subject] The piece function of a transplant which attains to a long period of time is secured, and the adequate amount of a required substance, for example, enzyme, and hormone is emitted, or finish crossing other required metabolism to a long period of time. [Solution means] The core containing the useful cell which is a vehicle of immunity interception nature transplantable in order to give activity output or function biologically to an individual, and was distributed in the biocompatibility matrix made from (a) hydrogel, (b) The vehicle of the immunity interception nature containing a jacket with the surface of the external diffusibility which surrounds this core made from biocompatibility hydrogel material that does not contain the above-mentioned cell projected outside from this core. As this raw きた cell, an insulin production cell, adrenal gland enterochromaffin cells, an antibody secretory cell, a fibroblast, a nerve glue astrocyte, a beta cell, and the ovarian cells of a Chinese hamster are desirable, and the alginic acid salt over which the bridge was constructed with the multivalent ion is desirable as a material of this hydrogel. [Selection figure] Nothing
Term
No projected expiry on record.
- Priority
- Filed
- Granted
- Today
68 members in 24 offices
Priority claims4
| Document | Office | Kind | Date |
|---|---|---|---|
| 69240391 | United States of America | A | |
| 69240391 | United States of America | A | |
| 692403 | – | – | – |
| US19910692403 | – | – | – |
Members68
| Document | Office | Kind | |
|---|---|---|---|
| CA2109085A1 | Canada | A1 | |
| WO9219195A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU2004192A | Australia | A | |
| NO933842L | Norway | L | |
| FI934545A | Finland | A | |
| EP0585368A1 | European Patent Office (EPO) | A1 | |
| EP0585368A4 | European Patent Office (EPO) | A4 | |
| CA2149420A1 | Canada | A1 | |
| WO9410950A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU5671394A | Australia | A | |
| JPH06507412A | Japan | A | |
| NO951914D0 | Norway | D0 | |
| NO951914L | Norway | L | |
| HU9501426D0 | Hungary | D0 | |
| FI952322A | Finland | A | |
| PL309012A1 | Poland | A1 | |
| EP0674497A1 | European Patent Office (EPO) | A1 | |
| SK62495A3 | Slovakia | A3 | |
| KR950703910A | Republic of Korea | A | |
| LV10906A | Latvia | A | |
| AU3902095A | Australia | A | |
| AU666118B2 | Australia | B2 | |
| CZ122795A3 | Czechia | A3 | |
| JPH08503472A | Japan | A | |
| LV10906B | Latvia | B | |
| HUT72986A | Hungary | A | |
| NZ258720A | New Zealand | A | |
| EP0585368B1 | European Patent Office (EPO) | B1 | |
| AT156344TThis record | Austria | T | |
| EP0674497A4 | European Patent Office (EPO) | A4 | |
| DE69221484D1 | Germany | D1 | |
| AU682796B2 | Australia | B2 | |
| ES2107537T3 | Spain | T3 | |
| DE69221484T2 | Germany | T2 | |
| AU687371B2 | Australia | B2 | |
| GR3025301T3 | Greece | T3 | |
| DK0585368T3 | Denmark | T3 | |
| SG47470A1 | Singapore | A1 | |
| AU6488398A | Australia | A | |
| HK1001832A1 | Hong Kong, China | A1 | |
| US5798113A | United States of America | A | |
| US5800828A | United States of America | A | |
| US5800829A | United States of America | A | |
| US5834001A | United States of America | A | |
| AU700766B2 | Australia | B2 | |
| US5869077A | United States of America | A | |
| US5871767A | United States of America | A | |
| US5874099A | United States of America | A | |
| BR9307455A | Brazil | A | |
| US5955095A | United States of America | A | |
| US6083523A | United States of America | A | |
| NO308198B1 | Norway | B1 | |
| US6322804B1 | United States of America | B1 | |
| US6337088B1 | United States of America | B1 | |
| EP0674497B1 | European Patent Office (EPO) | B1 | |
| AT220883T | Austria | T | |
| DE69332149D1 | Germany | D1 | |
| US2002150603A1 | United States of America | A1 | |
| DK0674497T3 | Denmark | T3 | |
| PT674497E | Portugal | E | |
| ES2179839T3 | Spain | T3 | |
| DE69332149T2 | Germany | T2 | |
| CA2109085C | Canada | C | |
| US2004185083A1 | United States of America | A1 | |
| US6960351B2 | United States of America | B2 | |
| CA2149420C | Canada | C | |
| JP2007314569A | Japan | A | |
| JP4215273B2 | Japan | B2 |
1 legal event, as the office reported them to INPADOC
Events
| Event | Code | |
|---|---|---|
| Publication of translation of european patent specificationUEP | UEP |
Numbers
- Publication, DOCDB
- 156344
- Publication, EPODOC
- AT156344T
- Application
- 92912606
- Application, DOCDB
- 92912606
- Application, EPODOC
- AT19920912606T
Titles2
- German
- IMPLANTIERBARE, BIOKOMPATIBLE IMMUNISOLATOR- TRÄGERSUBSTANZ ZUM ABGEBEN AUSGESUCHTER, THERAPEUTISCHER PRODUKTE
- English
- IMPLANTABLE, BIO-COMPATIBLE IMMUNISOLATOR SUPPORT FOR THE DISPOSAL OF SELECTED, THERAPEUTIC PRODUCTS
Classification
- CPC, 28
- A61K9/0092
- A61K9/0024
- A61K9/4816
- A61K35/12
- A61K35/30
- A61K35/39
- A61K38/185
- A61K48/00
- A61K2035/126
- A61K2035/128
- C12N5/0012
- A61P3/10
- C12N5/0062
- A61P5/24
- C12N5/0614
- A61P15/00
- C12N5/0656
- A61P25/00
- C12N5/0677
- A61P25/14
- C12N2510/02
- A61P25/28
- Y10S514/814
- A61P31/18
- Y10S514/866
- A61P37/02
- A61P37/06
- A61P43/00
- IPC, 15
- A61F2 02
- A61K9 00
- A61K9 48
- A61K9 50
- A61K35 12
- A61K35 30
- A61K35 39
- A61K38 18
- A61K39 395
- A61K47 36
- A61K48 00
- A61L27 00
- C12N5 00
- C12N5 071
- C12N5 077